We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Gilead Sciences Inc | NASDAQ:GILD | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.275 | -0.42% | 65.235 | 65.23 | 65.24 | 65.80 | 64.89 | 65.75 | 2,363,689 | 18:33:09 |
From May 2019 to May 2024
LONDON-- The European Medicines Agency Friday confirmed a risk of slow heart rate or problems with conduction of electrical signals in the heart when the hepatitis C medicines Harvoni, produced by Gilead Sciences Inc. (GILD), or a combination of Gilead's Sovaldi and Bristol-Myers Squibb Co's (BMY) Daklinza are used in patients who are also taking the medicine amiodarone.
-Write to Rory Gallivan at rory.gallivan@wsj.com; Twitter: @RoryGallivan
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Gilead Sciences Chart |
1 Month Gilead Sciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
